November 2, 2024

Heart Attack Survivors Less Likely To Develop Parkinson’s Disease

Individuals who have had a cardiovascular disease are at increased risk of stroke and vascular dementia; nevertheless, a brand-new research study found they may be less likely to develop Parkinsons disease.
A large, across the country research study in Denmark discovered that the threat of Parkinsons illness was moderately lower among people who have actually had a cardiac arrest than among the basic population.

Individuals who have actually had a cardiovascular disease may be somewhat less most likely than people in the general population to establish Parkinsons disease later on in life, according to new research published just recently in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
Parkinsons disease is a brain condition identified by progressive loss of physical motion, consisting of tremors, slow or slurred speech, and/or tightness or minimal variety of motion for strolling and other physical activities. There is no remedy for Parkinsons disease, and it is likewise related to behavioral modifications, anxiety, memory loss, and tiredness. Secondary parkinsonism, which has symptoms comparable to Parkinsons disease, might be triggered by stroke, psychiatric or cardiovascular medications, or other illness.

“These findings show that the threat of Parkinsons illness is at least not increased following a heart attack and should not be a concern for patients or a preventive focus for clinicians at follow-up.
” It is not understood whether this inverse relationship with risk of Parkinsons illness encompasses individuals who have had a cardiac arrest. For that reason, we analyzed the long-term threat of Parkinsons disease and secondary parkinsonism among heart attack survivors,” Sundbøll stated.
The scientists examined health windows registries from the Danish National Health Service. They compared the threat of Parkinsons disease and secondary parkinsonism amongst about 182,000 clients who had a newbie cardiovascular disease in between 1995 and 2016 (typical age 71 years old; 62% male) and more than 909,000 controls matched for age, sex and year of heart attack diagnosis. The outcomes were changed for a range of aspects understood to influence the danger of either cardiovascular disease or Parkinsons illness.
Over an optimum continuous follow-up of 21 years, after adjusting for a vast array of potential confounding factors, the analysis found that, when compared to the control group:

” For physicians dealing with clients following a cardiac arrest, these results show that cardiac rehab needs to be concentrated on preventing ischemic stroke, vascular dementia and other cardiovascular illness such as a new cardiovascular disease and cardiac arrest, because the risk of Parkinsons appears to be decreased in these clients, in comparison to the general population,” Sundbøll said.
Cardiac arrest and Parkinsons illness share certain threat factors, with greater threat discovered among elderly guys and lower threat among people who consume more coffee and are more physically active. Remarkably, however, some traditional threat aspects for a cardiovascular disease– such as cigarette smoking, high cholesterol, hypertension and Type 2 diabetes– are connected with a lower risk of Parkinsons disease.
In general, more cardiovascular disease patients smoke and have elevated cholesterol, either of which may discuss the somewhat lowered risk of Parkinsons disease amongst cardiac arrest survivors.
” There are extremely few illness in this world in which smoking cigarettes decreases danger: Parkinsons illness is one, and ulcerative colitis is another. Smoking cigarettes increases the threat of the most common diseases including cancer, heart disease and pulmonary disease and is certainly bad for your health,” Sundbøll kept in mind.
One constraint of the research study is that there was insufficient details about smoking cigarettes and high cholesterol levels among the individuals, which may have affected the findings. In addition, the research study population was significantly of white race/ethnicity, according to Sundbøll, for that reason, the findings might not be generalizable to individuals from varied racial or ethnic groups.
Reference: “Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors” by Jens Sundbøll, Szimonetta Komjáthiné Szépligeti, Péter Szentkúti, Kasper Adelborg, Erzsébet Horváth‐Puhó, Lars Pedersen, Victor W. Henderson and Henrik Toft Sørensen, 16 February 2022, Journal of the American Heart Association.DOI: 10.1161/ JAHA.121.022768.
Co-authors are Szimonetta Komjáthiné Szépligeti, M.Sc.; Péter Szentkúti, M.Sc.; Kasper Adelborg, M.D., Ph.D.; Erzsébet Horváth-Puhó, M.Sc., Ph.D.; Lars Pedersen, Ph.D.; Victor W. Henderson, M.D., M.S.; and Henrik Toft Sørensen, M.D., Ph.D., D.M.Sc.
The research study was funded by the Lundbeck Foundation.

there was a 20% lower danger of Parkinsons disease amongst people who had a heart attack; and
a 28% lower threat of secondary parkinsonism amongst those who had a heart attack.

“These findings suggest that the threat of Parkinsons illness is at least not increased following a heart attack and must not be a worry for patients or a preventive focus for clinicians at follow-up.
They compared the danger of Parkinsons disease and secondary parkinsonism amongst about 182,000 clients who had a first-time heart attack between 1995 and 2016 (typical age 71 years old; 62% male) and more than 909,000 controls matched for age, sex and year of heart attack diagnosis. The results were changed for a range of aspects known to influence the risk of either heart attack or Parkinsons illness.

Parkinsons disease is a brain disorder characterized by progressive loss of physical motion, including tremors, slurred or slow speech, and/or stiffness or restricted variety of movement for walking and other physical activities. Secondary parkinsonism, which has symptoms similar to Parkinsons disease, may be triggered by stroke, cardiovascular or psychiatric medications, or other health problem.